Eu­ro­pean biotech VC clos­es first fund with over $120M in the bank, thanks to big in­vestors

No­vo Hold­ings starts the new year off with a bang — right in­to a biotech VC’s first fund.

The firm an­nounced its undis­closed in­vest­ment — a “cor­ner­stone” in­vest­ment, ac­cord­ing to No­vo — this morn­ing in­to Sound Bioven­tures Fund I, a fund ap­pro­pri­ate­ly man­aged by Sound Bioven­tures. The ven­ture cap­i­tal firm aims to in­vest one-third of its fund in Scan­di­na­vian biotechs, an­oth­er third in US and UK biotechs, and the fi­nal third in oth­er Eu­ro­pean biotechs out­side Scan­di­navia and the UK.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER